Democratizing hedge fund level analysis tools for everyone
| About |
|---|
| PT Kalbe Farma Tbk, together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk is a subsidiary of PT Gira Sole Prima.. |
| Info | Profile |
|---|---|
| Name | Kalbe Farma Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 12/31/2024 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Public < 5% | 56.07 | 39.3 |
| Ladang Ira Panen, Pt | 10.46 | 10.46 |
| Gira Sole Prima, Pt | 10.29 | 10.29 |
| Santa Seha Sanadi, Pt | 10.07 | 10.07 |
| Bina Arta Charisma, Pt | 8.2 | 8.2 |
| Treasury Shares | 2.62 | 2.37 |
| Diptanala Bahana, Pt | 1.95 | 9.5 |
| Ronny Hadiana | 0.2 | 0.2 |
| Santoso Oen | 0.09 | 0.09 |
| B. R. Irawati Setiady | 0.05 | 0.05 |
| Lucasta Murni Cemerlang, Pt | 0.0 | 9.47 |
| Mulialie | 0.0 | 0.0 |
| Classification | Latest % | Previous % |
|---|---|---|
| Retail | 56.07 | 39.3 |
| Institution | 43.59 | 60.36 |
| Management | 0.29 | 0.29 |
| Individual | 0.05 | 0.05 |
| Revenue Source | 2023 | 2022 |
|---|---|---|
| Distribution and Logistic | 36.6% | 37.3% |
| Nutritionals | 26.2% | 27.1% |
| Prescription Pharmaceutical | 25.0% | 21.3% |
| Consumer Health | 12.2% | 14.3% |
| Others | 0.0% | 0.0% |
| Revenue Region | 2023 | 2022 |
|---|---|---|
| Indonesia | 93.8% | 94.2% |
| International | 6.2% | 5.8% |
| Others | 0.0% | 0.0% |
| Year | DPS | Yield [%] |
|---|---|---|
| 2024 | 31.0 | 2.1 |
| 2023 | 38.0 | 2.4 |
| 2022 | 35.0 | 1.7 |
| Timeframe | Performance |
|---|---|
| 1W % | 7.1 |
| 1Mo % | 31.4 |
| 3Mo % | 19.0 |
| 1Yr % | 5.6 |
| Pivot | Points |
|---|---|
| R2 | 1715 |
| R1 | 1545 |
| S1 | 1210 |
| S2 | 1045 |
Link download Laporan Keuangan emiten
| Stock | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 21.78 | 58.13 T | 58.24 T | 32,628 B | 5,069 B | 3,241 B |
| SIDO | 13.45 | 17.40 T | 16.99 T | 3,919 B | 1,577 B | 1,171 B |
| TSPC | 7.93 | 11.95 T | 10.82 T | 13,655 B | 2,114 B | 1,448 B |
| SOHO | 18.53 | 8.25 T | 10.52 T | 10,058 B | 618 B | 463 B |
| KAEF | -4.88 | 2.39 T | 12.98 T | 10,486 B | -9 B | -562 B |
| PYFA | -8.41 | 2.20 T | 6.62 T | 1,921 B | -37 B | -330 B |